Embryonic stem cells in cardiac repair and regeneration

Antioxidants and Redox Signaling

Volumn 11, Issue 8, 2009, Pages 1857-1863

  Singla, Dinender K ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

APOPTOSIS; AUTOCRINE EFFECT; CELL DIFFERENTIATION; DONOR; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENGRAFTMENT; HEART MUSCLE CELL; HEART REGENERATION; HUMAN; MEDIATOR RELEASE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL TRANSPLANTATION; TERATOMA; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; EMBRYONIC STEM CELLS; HEART; REGENERATION; STEM CELL TRANSPLANTATION; TERATOMA;

EID: 67650257526     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2491     Document Type: Review

References (63)

1. Anversa P, Leri A, Kajstura J, and Nadal-Ginard B. Myocyte growth and cardiac repair. JMol Cell Cardiol 34: 91-105,2002.
2. Anversa P, Olivetti G, Leri A, Liu Y, and Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 6: 169-176, 1997.
3. Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, and Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J16:1558-1566,2002.
4. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P, Hagege AA, and Menasche P. Transplantation of autolo- gous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108(suppl 1): II247-II252, 2003.
5. Chen TL, Wang JA, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, Zhang X, and Cao J. Cyclosporin A pre-incubation attenuates hypoxia/reoxygenation-induced apoptosis in mesen- chymal stem cells. Scand J Clin Lab Invest 1-9, 2008. Epub ahead of print.
6. Dell'Era P, Ronca R, Coco L, Nicoli S, Metra M, and Presta M. Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ Res 93: 414-420, 2003.
7. Emgard M, Hallin U, Karlsson J, Bahr BA, Brundin P, and Blomgren K. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem 86: 1223-1232, 2003.
8. Gertow K, Wolbank S, Rozell B, Sugars R, Andang M, Parish CL, Imreh MP, Wendel M, and Ehrlund-Richter L. Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev 13: 421-435, 2004.
9. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, and Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368, 2005.
10. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, and Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20: 661-669, 2006.
11. Guerette B, Skuk D, Celestin F, Huard C, Tardif F, Asselin I, Roy B, Goulet M, Roy R, Entman M, and Tremblay JP. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol 159: 2522-2531, 1997.
12. Haider HK and Ashraf M. Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 38: 225-235, 2005.
13. Haider HK and Ashraf M. Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol 288: H2557-H2567, 2005.
14. Haider HK, Ye L, and Ashraf M. Skeletal muscle derived stem cells for myocardial repair. Recent Patents Cardiovasc Drug Discov 2: 205-213, 2007.
15. Hayashi M, Li TS, Ito H, Mikamo A, and Hamano K. Comparison of intramyocardial and intravenous routes of delivering bone marrow cells for the treatment of ischemic heart disease: an experimental study. Cell Transplant 13: 639-647, 2004.
16. Hodgson DM, Behfar A, Zingman LV, Kane GC, Perez- Terzic C, Alekseev AE, Puceat M, and Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287: H471-H479, 2004.
17. Holmes JW, Borg TK, and Covell JW. Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng 7: 223-253, 2005.
18. Jayakumar J, Suzuki K, Khan M, Smolenski RT, Farrell A, Latif N, Raisky O, Abunasra H, Sammut IA, Murtuza B, Amrani M, and Yacoub MH. Gene therapy for myocardial protection: transfection of donor hearts with heat shock protein 70 gene protects cardiac function against ischemia- reperfusion injury. Circulation 102: III302-III306, 2000.
19. Jugdutt BI. Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways. Curr Drug Targets Cardiovasc Haematol Disord 3: 1-30, 2003.
20. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108: 1395-1403, 2003.
21. Jugdutt BI, Menon V, Kumar D, and Idikio H. Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril. J Am Coll Cardiol 39: 1538-1545, 2002.
22. Kawai T, Takahashi T, Esaki M, Ushikoshi H, Nagano S, Fujiwara H, and Kosai K. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J 68: 691-702, 2004.
23. Kofidis T, de Bruin JL, Yamane T, Balsam LB, Lebl DR, Swij- nenburg RJ, Tanaka M, Weissman IL, and Robbins RC. Insulinlike growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22: 1239-1245, 2004.
24. Kofidis T, de Bruin JL, Yamane T, Tanaka M, Lebl DR, Swijnenburg RJ, Weissman IL, and Robbins RC. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation 111: 2486-2493, 2005.
25. Kuai XL, Cong XQ, Du ZW, Bian YH, and Xiao SD. Treatment of surgically induced acute liver failure by transplantation of HNF4-overexpressing embryonic stem cells. Chin J Dig Dis 7: 109-116, 2006.
26. Kumar D, Kamp TJ, and LeWinter MM. Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration. Coron Artery Dis 16: 111-116, 2005.
27. Laumonier T, Yang S, Konig S, Chauveau C, Anegon I, Hoffmeyer P, and Menetrey J. Lentivirus mediated HO-1 gene transfer enhances myogenic precursor cell survival after autologous transplantation in pig. Mol Ther 16: 404-410, 2008.
28. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lutzow K, Lendlein A, Stamm C, Li RK, and Steinhoff G. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25: 2118-2127, 2007.
29. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grogaard HK, Bjornerheim R, Brekke M, Muller C, Hopp E, Ragnarsson A, Brinchmann JE, and Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355: 1199-1209, 2006.
30. Menard C, Hagege AA, Agbulut O, Barro M, Morichetti MC, Brasselet C, Bel A, Messas E, Bissery A, Bruneval P, Desnos M, Puceat M, and Menasche P. Transplantation of cardiac- committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366: 1005-1012, 2005.
31. Menasche P. Cellular transplantation: hurdles remaining before widespread clinical use. Curr Opin Cardiol 19: 154-161, 2004.
32. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, and Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113: 1287-1294, 2006.
33. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, and Xiao YF. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol 92: 288-296, 2002.
34. Moriya K, Yoshikawa M, Saito K, Ouji Y, Nishiofuku M, Hayashi N, Ishizaka S, and Fukui H. Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice. World J Gastroenterol 13: 866-873, 2007.
35. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, Laird PW, and Kedes L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol 34: 107-116, 2002.
36. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Naka- jima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, and Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668, 2004.
37. Nakamura Y, Yasuda T, Weisel RD, and Li RK. Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. Am J Physiol Heart Circ Physiol 291: H939-H947, 2006.
38. Nakano M, Matsumoto I, Sawada T, Ansite J, Oberbroeck- ling J, Zhang HJ, Kirchhof N, Shearer J, Sutherland DE, and Hering BJ. Caspase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves islet graft function. Pancreas 29: 104-109, 2004.
39. Niagara MI, Haider HK, Jiang S, and Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 100: 545-555, 2007.
40. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H, and Murry CE. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 171: 431-440, 2007.
41. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001.
42. Puceat M. TGFbeta in the differentiation of embryonic stem cells. Cardiovasc Res 74: 256-261, 2007.
43. Reubinoff BE, Pera MF, Fong CY, Trounson A, and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18: 399-404, 2000.
44. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, and Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44: 1690-1699, 2004.
45. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, olschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, and Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. NEnglJMed355: 1210-1221, 2006.
46. Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, and Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat Med 5: 97-100, 1999.
47. Singla DK, Hacker TA, Ma L, Douglas PS, Sullivan R, Lyons GE, and Kamp TJ. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 40: 195-200, 2006.
48. Singla DK, Lyons GE, and Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293: H1308-H1314, 2007.
49. Singla DK and McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol 293: H1590-H1595, 2007.
50. Singla DK and Sobel BE. Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration. Biochem Biophys Res Commun 335: 637-642, 2005.
51. Singla DK and Sun B. Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun 332: 135-141, 2005.
52. Skuk D, Caron NJ, Goulet M, Roy B, and Tremblay JP. Resetting the problem of cell death following muscle-derived cell transplantation: detection, dynamics and mechanisms. J Neuropathol Exp Neurol 62: 951-967, 2003.
53. Spinale FG. Matrix metalloproteinases: regulation and dys-regulation in the failing heart. Circ Res 90: 520-530, 2002.
54. Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, and Yacoub MH. Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110: II219-II224, 2004.
55. Suzuki K, Smolenski RT, Jayakumar J, Murtuza B, Brand NJ, and Yacoub MH. Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102: III216-III221, 2000.
56. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl DR, Caffarelli AD, de Bruin JL, Fedoseyeva EV, and Robbins RC. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into is- chemic myocardium. Circulation 112: I166-I172, 2005.
57. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
58. Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, and Zhang X. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesen- chymal stem cells. Acta Pharmacol Sin 29: 74-82, 2008.
59. Weber KT. Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation 102: 1342-1345, 2000.
60. Weber KT. From inflammation to fibrosis: a stiff stretch of highway. Hypertension 43: 716-719, 2004.
61. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, and Drexler H. In- tracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364: 141-148, 2004.
62. Xie X, Cao F, Sheikh AY, Li Z, Connolly AJ, Pei X, Li RK, Robbins RC, and Wu JC. Genetic modification of embryonic stem cells with VEGF enhances cell survival and improves cardiac function. Cloning Stem Cells 9: 549-563, 2007.
63. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, and Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921, 2001.